Syndevrx, Inc.
Clinical trials sponsored by Syndevrx, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New triple therapy aims to control advanced breast cancer with fewer side effects Results expected Dec 2026 (estimated)